Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action

Both amyloid-&#946; (A&#946;) and insulin are amyloidogenic peptides, and they play a critical role in Alzheimer&#8217;s disease (AD) and type-2 diabetes (T2D). Misfolded or aggregated A&#946; and glycated insulin are commonly found in AD and T2D patients, respectively, and exhibit n...

Full description

Bibliographic Details
Main Authors: Su Hui Seong, Pradeep Paudel, Hyun Ah Jung, Jae Sue Choi
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/17/11/600
_version_ 1828146338106179584
author Su Hui Seong
Pradeep Paudel
Hyun Ah Jung
Jae Sue Choi
author_facet Su Hui Seong
Pradeep Paudel
Hyun Ah Jung
Jae Sue Choi
author_sort Su Hui Seong
collection DOAJ
description Both amyloid-&#946; (A&#946;) and insulin are amyloidogenic peptides, and they play a critical role in Alzheimer&#8217;s disease (AD) and type-2 diabetes (T2D). Misfolded or aggregated A&#946; and glycated insulin are commonly found in AD and T2D patients, respectively, and exhibit neurotoxicity and oxidative stress. The present study examined the anti-A&#946;<sub>25-35</sub> aggregation and anti-insulin glycation activities of five phlorotannins isolated from <i>Ecklonia stolonifera</i>. Thioflavin-T assay results suggest that eckol, dioxinodehydroeckol, dieckol, and phlorofucofuroeckol-A (PFFA) significantly inhibit A&#946;<sub>25-35</sub> self-assembly. Molecular docking and dynamic simulation analyses confirmed that these phlorotannins have a strong potential to interact with A&#946;<sub>25-35</sub> peptides and interrupt their self-assembly and conformational transformation, thereby inhibiting A&#946;<sub>25-35</sub> aggregation. In addition, PFFA dose-dependently inhibited <span style="font-variant: small-caps;">d</span>-ribose and <span style="font-variant: small-caps;">d</span>-glucose induced non-enzymatic insulin glycation. To understand the molecular mechanism for insulin glycation and its inhibition, we predicted the binding site of PFFA in insulin via computational analysis. Interestingly, PFFA strongly interacted with the Phe1 in insulin chain-B, and this interaction could block <span style="font-variant: small-caps;">d</span>-glucose access to the glycation site of insulin. Taken together, our novel findings suggest that phlorofucofuroeckol-A could be a new scaffold for AD treatment by inhibiting the formation of &#946;-sheet rich structures in A&#946;<sub>25-35</sub> and advanced glycation end-products (AGEs) in insulin.
first_indexed 2024-04-11T20:45:59Z
format Article
id doaj.art-21703ea26d7a42d38ccb9af4c6f5f8ca
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T20:45:59Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-21703ea26d7a42d38ccb9af4c6f5f8ca2022-12-22T04:04:02ZengMDPI AGMarine Drugs1660-33972019-10-01171160010.3390/md17110600md17110600Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of ActionSu Hui Seong0Pradeep Paudel1Hyun Ah Jung2Jae Sue Choi3Department of Food and Life Science, Pukyong National University, Busan 48513, KoreaDepartment of Food and Life Science, Pukyong National University, Busan 48513, KoreaDepartment of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, KoreaDepartment of Food and Life Science, Pukyong National University, Busan 48513, KoreaBoth amyloid-&#946; (A&#946;) and insulin are amyloidogenic peptides, and they play a critical role in Alzheimer&#8217;s disease (AD) and type-2 diabetes (T2D). Misfolded or aggregated A&#946; and glycated insulin are commonly found in AD and T2D patients, respectively, and exhibit neurotoxicity and oxidative stress. The present study examined the anti-A&#946;<sub>25-35</sub> aggregation and anti-insulin glycation activities of five phlorotannins isolated from <i>Ecklonia stolonifera</i>. Thioflavin-T assay results suggest that eckol, dioxinodehydroeckol, dieckol, and phlorofucofuroeckol-A (PFFA) significantly inhibit A&#946;<sub>25-35</sub> self-assembly. Molecular docking and dynamic simulation analyses confirmed that these phlorotannins have a strong potential to interact with A&#946;<sub>25-35</sub> peptides and interrupt their self-assembly and conformational transformation, thereby inhibiting A&#946;<sub>25-35</sub> aggregation. In addition, PFFA dose-dependently inhibited <span style="font-variant: small-caps;">d</span>-ribose and <span style="font-variant: small-caps;">d</span>-glucose induced non-enzymatic insulin glycation. To understand the molecular mechanism for insulin glycation and its inhibition, we predicted the binding site of PFFA in insulin via computational analysis. Interestingly, PFFA strongly interacted with the Phe1 in insulin chain-B, and this interaction could block <span style="font-variant: small-caps;">d</span>-glucose access to the glycation site of insulin. Taken together, our novel findings suggest that phlorofucofuroeckol-A could be a new scaffold for AD treatment by inhibiting the formation of &#946;-sheet rich structures in A&#946;<sub>25-35</sub> and advanced glycation end-products (AGEs) in insulin.https://www.mdpi.com/1660-3397/17/11/600phlorotanninamyloid-β aggregationinsulin glycationdynamic simulation
spellingShingle Su Hui Seong
Pradeep Paudel
Hyun Ah Jung
Jae Sue Choi
Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
Marine Drugs
phlorotannin
amyloid-β aggregation
insulin glycation
dynamic simulation
title Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
title_full Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
title_fullStr Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
title_full_unstemmed Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
title_short Identifying Phlorofucofuroeckol-A as a Dual Inhibitor of Amyloid-β<sub>25-35</sub> Self-Aggregation and Insulin Glycation: Elucidation of the Molecular Mechanism of Action
title_sort identifying phlorofucofuroeckol a as a dual inhibitor of amyloid β sub 25 35 sub self aggregation and insulin glycation elucidation of the molecular mechanism of action
topic phlorotannin
amyloid-β aggregation
insulin glycation
dynamic simulation
url https://www.mdpi.com/1660-3397/17/11/600
work_keys_str_mv AT suhuiseong identifyingphlorofucofuroeckolaasadualinhibitorofamyloidbsub2535subselfaggregationandinsulinglycationelucidationofthemolecularmechanismofaction
AT pradeeppaudel identifyingphlorofucofuroeckolaasadualinhibitorofamyloidbsub2535subselfaggregationandinsulinglycationelucidationofthemolecularmechanismofaction
AT hyunahjung identifyingphlorofucofuroeckolaasadualinhibitorofamyloidbsub2535subselfaggregationandinsulinglycationelucidationofthemolecularmechanismofaction
AT jaesuechoi identifyingphlorofucofuroeckolaasadualinhibitorofamyloidbsub2535subselfaggregationandinsulinglycationelucidationofthemolecularmechanismofaction